Pfizer and Strides Arcolab entered a new collaboration under which Pfizer will commercialize off-patent sterile injectable and oral products in the U.S. through its Established Products Business Unit. These finished dosage form products will be licensed and supplied by Strides and Onco Laboratories Ltd. and Onco Therapies Ltd., two joint ventures between Strides and Aspen, South Africa, in which each owns 50%. Financial terms were not disclosed. The companies anticipate that the collaboration...